Histone modifications change with age, dietary restriction and rapamycin 
treatment in mouse brain

Gong, H.; Qian, H.; Ertl, R.; Astle, C. M.; Wang, G. G.; Harrison, D. E.; Xu, X.

doi:10.18632/oncotarget.4137

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Histone modifications change with age, dietary restriction and rapamycin treatment in mouse brain

MPS-Authors

/persons/resource/persons179773

Xu, X.
Xu – Epigenetic Regulation of Mammalian Ageing, Research Groups, Max Planck Institute for Biology of Ageing, Max Planck Society;

External Resource

http://www.ncbi.nlm.nih.gov/pubmed/26021816
(全文テキスト（全般）)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Gong, H., Qian, H., Ertl, R., Astle, C. M., Wang, G. G., Harrison, D. E., & Xu, X. (2015). Histone modifications change with age, dietary restriction and rapamycin treatment in mouse brain. Oncotarget, 6(18), 15882-90. doi:10.18632/oncotarget.4137.

引用: https://hdl.handle.net/21.11116/0000-000B-9D77-F

要旨

The risk of developing neurodegenerative disorders such as Alzheimer's disease (AD) increases dramatically with age. Understanding the underlying mechanisms of brain aging is crucial for developing preventative and/or therapeutic approaches for age-associated neurological diseases. Recently, it has been suggested that epigenetic factors, such as histone modifications, maybe be involved in brain aging and age-related neurodegenerations. In this study, we investigated 14 histone modifications in brains of a cohort of young (3 months), old (22 months), and old age-matched dietary restricted (DR) and rapamycin treated BALB/c mice. Results showed that 7 out of all measured histone markers were changed drastically with age. Intriguingly, histone methylations in brain tissues, including H3K27me3, H3R2me2, H3K79me3 and H4K20me2 tend to disappear with age but can be partially restored by both DR and rapamycin treatment. However, both DR and rapamycin treatment also have a significant impact on several other histone modifications such as H3K27ac, H4K16ac, H4R3me2, and H3K56ac, which do not change as animal ages. This study provides the first evidence that a broad spectrum of histone modifications may be involved in brain aging. Besides, this study suggests that both DR and rapamycin may slow aging process in mouse brain via these underlying epigenetic mechanisms.